Skip to content
Boston Strategic Partners, Inc.

Boston Strategic Partners, Inc.

Your partner in delivering healthcare solutions

  • Home
  • About
    • BSP Professionals
    • Events Calendar
  • Services
    • Business and Clinical Strategy
    • Health Economics and Outcomes Research
    • Medical Communications
    • Regulatory Strategy
    • Financial Advisory
  • Electronic Health Record (EHR) Data
    • Explore our Data
    • Selected Publications leveraging EHR Data
    • App Development
  • News
    • News
    • Publications
  • Careers
  • Contact
  • Real World Reports

Business and Clinical Strategy

Health Economics and Outcomes Research

Medical Communications

Regulatory Strategy

Financial Advisory

Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome

March 30, 2017 katarinachin

Shaw AD, Schermer CR, Lobo DN, Munson SH, Khangulov V, Hayashida D, Kellum JA. Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome. Crit Care. 2015;19:334. doi:10.1186/s13054-015-1045-z.

View article

Posted in PublicationsTagged Critical Care Medicine, HEOR, Retrospective Study

Post navigation

Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation
A Pooled Analysis Evaluating Renal Safety in Placebo- and Active Comparator-Controlled Phase III Trials of Multiple-Dose Injectable HPβCD-Diclofenac in Subjects with Acute Postoperative Pain

Connect

4 Wellington St.
Suite 3
Boston, MA 02118
+1 617-446-3440
info@bostonsp.com

Discover

  • News
  • Real World Reports
  • Electronic Health Record (EHR) Data
  • Publications
  • App Development
  • Events Calendar

Learn

  • About
  • Careers
  • Services
  • Contact
  • Sitemap

© Copyright 2019 Boston Strategic Partners, Inc. All rights reserved.

This site uses cookies: Find out more.